X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ASTRAZENECA PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ASTRAZENECA PHARMA MERCK LTD/
ASTRAZENECA PHARMA
 
P/E (TTM) x 33.9 113.4 29.9% View Chart
P/BV x 3.8 16.2 23.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 MERCK LTD   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ASTRAZENECA PHARMA
Mar-14
MERCK LTD/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0601,285 82.5%   
Low Rs623634 98.3%   
Sales per share (Unadj.) Rs632.4189.6 333.6%  
Earnings per share (Unadj.) Rs45.7-0.2 -22,454.3%  
Cash flow per share (Unadj.) Rs62.33.8 1,620.9%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.868.6 566.5%  
Shares outstanding (eoy) m16.6025.00 66.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.35.1 26.3%   
Avg P/E ratio x18.4-4,712.7 -0.4%  
P/CF ratio (eoy) x13.5249.6 5.4%  
Price / Book Value ratio x2.214.0 15.5%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,96923,988 58.2%   
No. of employees `0001.61.6 101.5%   
Total wages/salary Rs m1,4871,605 92.7%   
Avg. sales/employee Rs Th6,631.93,040.2 218.1%   
Avg. wages/employee Rs Th939.21,029.2 91.2%   
Avg. net profit/employee Rs Th479.4-3.3 -14,683.6%   
INCOME DATA
Net Sales Rs m10,4984,740 221.5%  
Other income Rs m24292 263.2%   
Total revenues Rs m10,7414,832 222.3%   
Gross profit Rs m1,135-130 -874.7%  
Depreciation Rs m276101 272.2%   
Interest Rs m00-   
Profit before tax Rs m1,102-139 -793.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m3435 6,744.6%   
Profit after tax Rs m759-5 -14,909.6%  
Gross profit margin %10.8-2.7 -394.9%  
Effective tax rate %31.1-3.7 -850.0%   
Net profit margin %7.2-0.1 -6,731.3%  
BALANCE SHEET DATA
Current assets Rs m6,4102,726 235.1%   
Current liabilities Rs m8,8282,435 362.6%   
Net working cap to sales %-23.06.1 -374.8%  
Current ratio x0.71.1 64.8%  
Inventory Days Days5874 78.2%  
Debtors Days Days3841 94.2%  
Net fixed assets Rs m1,4061,035 135.8%   
Share capital Rs m16650 332.0%   
"Free" reserves Rs m6,286942 667.0%   
Net worth Rs m6,4551,716 376.1%   
Long term debt Rs m00-   
Total assets Rs m8,8284,156 212.4%  
Interest coverage xNMNM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.21.1 104.3%   
Return on assets %8.6-0.1 -7,018.8%  
Return on equity %11.8-0.3 -3,963.8%  
Return on capital %17.10-  
Exports to sales %8.35.7 145.3%   
Imports to sales %21.06.5 325.6%   
Exports (fob) Rs m869270 321.8%   
Imports (cif) Rs m2,209306 721.3%   
Fx inflow Rs m959375 256.0%   
Fx outflow Rs m2,612470 555.6%   
Net fx Rs m-1,653-96 1,730.2%   
CASH FLOW
From Operations Rs m1,070-8 -13,214.8%  
From Investments Rs m-750-146 514.6%  
From Financial Activity Rs m-150862 -17.4%  
Net Cashflow Rs m171709 24.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 0.3 6,066.7%  
FIIs % 1.0 15.7 6.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 9.1 319.8%  
Shareholders   28,591 12,856 222.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 18, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS